HOME Press Releases Advanced Wound Care Market worth 13.07 Billion USD by 2022



Advanced Wound Care Market worth 13.07 Billion USD by 2022


The report "Advanced Wound Care Market by Product (Dressings (Foams, Hydrocolloids, Alginates), Therapy Devices, NPWT, Autograft, Allograft, Xenograft), Wound (Surgical, Trauma, Diabetic Foot, Ulcers, Burns), End User (Hospital, Home Care) - Global Forecast to 2022", The global advanced wound care market is expected to reach USD 13.07 Billion by 2022 from USD 10.43 Billion in 2017, at a CAGR of 4.6%. Factors driving the growth of this market include the increasing prevalence of surgical wounds & ulcers (diabetic foot ulcers, pressure ulcers, and venous leg ulcers), increasing aging population, increasing demand for evidence- based advanced wound care products, rising R&D activities, advancements in the field of advanced wound care research, and increasing awareness about wound care treatment.

                                              Request Sample                     Request Sample

Browse 199 Market Data Tables and 66 Figures spread through 220 Pages and in-depth TOC on "Advanced Wound Care Market by Product (Dressings (Foams, Hydrocolloids, Alginates), Therapy Devices, NPWT, Autograft, Allograft, Xenograft), Wound (Surgical, Trauma, Diabetic Foot, Ulcers, Burns), End User (Hospital, Home Care) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/advanced-wound-care-market-88705076.html
Early buyers will receive 10% customization on reports.

Moist wound dressings are estimated to account for the largest market share in 2017

By product, the advanced wound care market is segmented into moist wound dressings, wound therapy devices, and active wound care. The moist wound dressings segment is further subcategorized into foam, hydrocolloid, film, alginate, hydrogel, and collagen dressings. The increasing incidence of target indications, such as diabetic ulcers, venous ulcers, and pressure ulcers, is expected to support the demand for moist wound dressings during the forecast period.

The surgical wounds segment is estimated to dominate the market in 2017

By wound type, the market is categorized into surgical wounds, ulcers, traumatic wounds, burns, and other wounds. The surgical wounds segment is projected to account for the largest share of the global advanced wound care market. The large share of this segment can be attributed to factors such as rising incidence of diabetes and diabetic foot ulcers (due to the prevalence of pressure ulcers and venous leg ulcers in the geriatric population, increasing the demand for advanced wound care products).

By end user, hospitals and clinics are estimated to command for the largest share of the market

By end users, the advanced wound care market is categorized into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment is estimated to account for the largest share of the global advanced wound care market. Increasing patient admissions for the treatment of chronic wounds, rising incidence of diabetes, and improving hospital infrastructure in developing countries are key factors driving the growth of this end-user segment.

North America is estimated to command the largest share of the market

Based on region, the advanced wound care market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, North America is estimated to account for the largest share of the global wound care market. The large share of North America is attributed to the growing geriatric population, surging prevalence of chronic wounds, and product launches in this region.

The key players in the advanced wound care market are Smith & Nephew (UK), Mölnlycke Health Care (Sweden), B. Braun (Germany), ConvaTec Group (US), Coloplast (Denmark), Integra LifeSciences(US), 3M Company (US), Cardinal Health (US), Acelity L.P. (US), Medtronic (US), MPM Medical (US), PAUL HARTMANN (Germany), Medline Industries (US), Lohmann & Rauscher (Germany), Advanced Medical Solutions Group (UK), BSN medical GmbH (Germany), Wound Care Technologies (US), Vivostat A/S (Denmark), Organogenesis (US), Hematris Wound Care (Germany), Alliqua BioMedical (UK), MiMedX Group (US), Triage Meditech (India), DeRoyal Industries (US), and Laboratoires URGO (UK).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports